Track how companies discuss tariffs and trade policies in their earnings calls, and understand their impact across different industries and regions.
We have undertaken an initial review of the impact that tariffs may have on our business.
We can confidently report that we don't have material exposure in the near to midterm to any tariff-related price increases nor do we believe there is a substantial risk to our supply chain.
On the tariff front, we're in a good position to manage through the current uncertainty and minimize the potential impact to our business.
This increase over our previous estimate of $19 million to $21 million per satellite is primarily driven by higher launch costs from our announced near-term launch schedule as well as higher direct materials costs due to recently announced tariffs.
We do not anticipate that our Q1 volumes are purely indicative of the longer term trend, in particular as it relates to auto. We are of the view that what we likely experienced with some pull-forward of demand as selected consumers sought to get ahead of the potential impact of tariffs on auto prices.
We've seen minimal impact to date across the portfolio.
we don't currently believe either tariffs or Medicaid reform represent any material financial impact.
For CPI, tariffs have not and are not expected to be a significant issue for the business as most of our supply chain and raw material inputs are sourced domestically.
Increased economic uncertainty, exacerbated by significant shifts in trade policy in recent weeks, is expected to produce continued volatility.
we don't expect tariffs or global trade war to have a material impact on our current operations and are therefore very confident reaffirming our 2025 financial guidance.